Gene: MELK
Official Full Name: maternal embryonic leucine zipper kinaseprovided by HGNC
Gene Summary: Enables calcium ion binding activity; non-membrane spanning protein tyrosine kinase activity; and protein serine/threonine kinase activity. Involved in apoptotic process; cell population proliferation; and protein autophosphorylation. Located in cell cortex and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02343 | MELK Knockout cell line (HeLa) | Human | MELK | 1:3~1:6 | Negative | Online Inquiry |
KO02344 | MELK Knockout cell line (HCT 116) | Human | MELK | 1:2~1:4 | Negative | Online Inquiry |
KO02345 | MELK Knockout cell line (HEK293) | Human | MELK | 1:3~1:6 | Negative | Online Inquiry |
KO02346 | MELK Knockout cell line (A549) | Human | MELK | 1:3~1:4 | Negative | Online Inquiry |
MELK Gene Knockout Cell Lines are genetically engineered cell lines that specifically disrupt the expression of the MELK (Maternal Embryonic Leucine Zipper Kinase) gene, a serine/threonine kinase implicated in various cellular processes, including cell proliferation, differentiation, and apoptosis. The deletion of the MELK gene allows researchers to investigate the cellular consequences of MELK deficiency and its role in various biological pathways, particularly those associated with cancer progression and stem cell behavior.
The key mechanism of these cell lines involves the application of CRISPR-Cas9 technology, a powerful tool for targeted gene editing. By introducing a guide RNA that directs the Cas9 nuclease to the MELK gene sequence, precise cuts are made, leading to insertions or deletions that effectively knockout gene function. This method results in stable, reproducible cell lines that facilitate studies on gene function, protein interactions, and signaling pathways that are affected by MELK activity.
The scientific importance of MELK Gene Knockout Cell Lines extends to both basic research and potential clinical applications. These cell lines provide invaluable insights into the pathophysiology of malignancies and contribute to the identification of novel therapeutic targets. In particular, understanding the role of MELK in tumor growth and development can pave the way for innovative treatments in oncology.
Compared to alternative products that may only involve transient knockdown methodologies, MELK Gene Knockout Cell Lines offer the advantage of stable, long-term gene suppression, enabling continuous study of cellular effects over prolonged periods. Furthermore, the robustness of these cell lines allows for versatile applications across different experimental setups, enhancing their utility in both academia and industry.
Investing in MELK Gene Knockout Cell Lines provides researchers and clinicians with a reliable tool that can significantly advance their studies on cancer biology and therapeutic discovery. With a commitment to innovation and scientific excellence, our company is dedicated to providing high-quality biological products that support groundbreaking research endeavors in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.